A CU Medicine provider.

Dr. Marco Del Chiaro is a surgical oncologist with 15 years of experience in the treatment of pancreatic diseases. He is internationally recognized as a leader in the surgical treatment of borderline resectable\locally advanced pancreatic cancer, as well as in the diagnosis and treatment of pancreas lesions. Dr. Del Chiaro’s unique approach, combined with multimodal chemoradiotherapy, allows more surgical options for locally advanced pancreatic cancer patients. He is active in academic research, with more than 130 peer reviewed papers, and is a member of several scientific journals’ editorial boards. Dr. Del Chiaro’s mission is to improve pancreatic cancer survival through both prevention and aggressive treatment of the advanced tumors and to create a multimodal personalized treatment for each patient.


Monday: 8am - 5pm
Tuesday: 8am - 5pm
Wednesday: 8am - 5pm
Thursday: 8am - 5pm
Friday: 8am - 5pm
Saturday: Closed
Sunday: Closed
Monday: 8am - 4:30pm
Tuesday: 8am - 4:30pm
Wednesday: 8am - 4:30pm
Thursday: 8am - 4:30pm
Friday: 8am - 4:30pm
Saturday: Closed
Sunday: Closed
Monday: All day
Tuesday: All day
Wednesday: All day
Thursday: All day
Friday: All day
Saturday: All day
Sunday: All day

Qualifications and experience

Complex General Surgical Oncology, Surgery, Cancers - Biliary Cancer, Cancers, Cancers - Pancreatic Cancer, Digestive System - Pancreas Surgery, Digestive System, Digestive System - Biliary Surgery, Surgery - Pancreas Transplant Surgery, Cancers - Cancer Prevention, Cancers - Cancer Surgery, Cancers - Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver), Digestive System - Gastrointestinal Surgery
Languages spoken
Medical School
University of Pisa, Italy (1997)

Clinical interest for patients

Pancreas, Bile duct, Liver, Stomach, Adrenal, Sarcoma, and Cancer Surgery

UCHealth strongly encourages you to consult with your health insurer to determine accurate information about your coverage and benefits for a particular health care service provided at a UCHealth facility. Read more here.